Neogenetics is a certified laboratory active mainly in the area of expanded newborn screening. At 2011, as a spin out of Neoscreen, got a grant of 500.000 euros from the Greek ESPA (EΥDE ETAK) in order to expand its facilities. Since its establishment at 2011, until today, it collaborates with the major private maternity hospitals in Greece (like IASO, GAIA, IASO THESSALIA), and private health care doctors, for conducting prenatal and neonatal screening. In total, Neogenetics has performed more than 10,000 newborn screenings and more than 1,000 molecular screenings for (cystic fibrosis, spinal muscular atrophy and other metabolic diseases). Neogenetics is a company, staffed with highly scientific personnel and also possesses the latest technology equipment.
Recently has promoted its services to Pharmaceutical Industry performing Genotoxic Analysis of impurities, Pharmacogenetic Analysis and Method Validation of new products. These services are based on the new State of the Art Insrumentation got it through the Greek ESPA financial support.